Jane M. Hook

Leeds, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Diffuse cutaneous melanosis is an under-recognized sign with a poor prognosis in patients with melanoma.

Diffuse cutaneous melanosis is an under-recognized sign with a poor prognosis in patients with melanoma.

Journal: Clinical and experimental dermatology
Published: December 05, 2022

Characterisation of the onset and severity of adrenal and thyroid dysfunction associated with CTLA4-related hypophysitis.

Characterisation of the onset and severity of adrenal and thyroid dysfunction associated with CTLA4-related hypophysitis.

Journal: European journal of endocrinology
Published: July 27, 2021

The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma.

The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma.

Journal: BMC cancer
Published: January 09, 2021

Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial.

Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial.

Journal: The Lancet. Oncology
Published: February 18, 2020

Are we over-treating with checkpoint inhibitors?

Are we over-treating with checkpoint inhibitors?

Journal: British journal of cancer
Published: August 13, 2019

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.

Journal: Lancet (London, England)
Published: July 16, 2019

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.

Journal: The Lancet. Oncology
Published: March 24, 2016

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 03, 2015

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.

Journal: Lancet (London, England)
Published: May 24, 2015

EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.

EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 26, 2014

Maintenance therapy in ovarian cancer.

Maintenance therapy in ovarian cancer.

Journal: Current opinion in oncology
Published: July 18, 2014

Knowledge, ignorance and priorities for research in key areas of cancer survivorship: findings from a scoping review.

Knowledge, ignorance and priorities for research in key areas of cancer survivorship: findings from a scoping review.

Journal: British journal of cancer
Published: November 04, 2011
Showing 1-12 of 13

Last Updated: 09/26/2026